跳至主要内容
临床试验/CTRI/2025/12/098731
CTRI/2025/12/098731尚未招募不适用

Effect of exercise training on the inflammatory profile in patients with breast cancer undergoing chemotherapy: an open label randomised controlled trial

Dr Rose Babu1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2026年2月2日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
60
试验地点
1

研究概览

简要总结

This study is an open label single centered randomized controlled trial to determine the effect of exercise training on the inflammatory profile of patients with breast cancer undergoing chemotherapy -anthracycline and cyclophosphamide regimen, when compared to patients who are on treatment without any exercise intervention. A total of 60 patients will be recruited for the study and randomized into intervention and control groups.The primary outcome will be inflammatory markers like TNF-a, CRP which will be investigated at the baseline -before chemotherapy, at the middle of chemotherapy treatment cycles and at the end of chemotherapy cycles. The secondary outcome will be body composition, muscle strength, quality of life, investigated at the baseline, at the middle of chemotherapy treatment cycles and at the end of chemotherapy cycles and other outcomes like treatment toxicity and relative dose intensity will be investigated after each cycle of chemotherapy.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 80.00 Year(s)(—)
性别
Female

入选标准

  • Female patients who are diagnosed with breast cancer (Stage 1 to stage 3) and about to undergo neoadjuvant or adjuvant chemotherapy (cyclophosphamide-anthracycline regimen).
  • Normal cardiovascular, hepatic and renal function.
  • Patients who are willing to participate.

排除标准

  • Patients with Eastern Cooperative Oncology Group (ECOG) performance status more than
  • Currently with any musculoskeletal disturbances, severe respiratory illness, autoimmune diseases.
  • Patients who are pregnant.
  • Who had undergone major surgeries within past 3 months Known case of any psychiatric disorders, intellectual disabilities.
  • Under regular moderate to high intensity exercise (after calculation of physical activity level (PAL).
  • Receiving chronic anti-inflammatory medications for other diseases.

研究者

发起方
Dr Rose Babu
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Rose Babu

Jubilee Mission Medical College and Research Institute

研究点 (1)

Loading locations...

相似试验